Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Sharon Klahre – Vice President of Investor Relations and Strategic Finance Ankit Mahadevia – Chief Executive Officer David Melnick – Chief Medical Officer Cristina Larkin – Chief Operating Officer Steve DiPalma – Interim Chief Financial Officer Conference Call Participants Carvey Leung – Cantor Vishal Sethi – Cowen Ellen Sands – Stifel Operator Operator Good day, and welcome to the Spero ...